ESMO 2018 | Preventative and prognostic screening for BRCA mutations

Domenica Lorusso

Domenica Lorusso, MD, PhD, of the IRCCS National Cancer Institute, Milan, Italy, discusses the poor diagnostics for ovarian cancer, at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany. Preventative BRCA testing, for patients and extended family, is currently the best prognostic tool.

Share this video